EFFECTOR THERAPEUTICS INC (EFTR)
US28202V2079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -35.81M | -22.67M | 15.80M | 14.21M | -29.74M | |||
| Depreciation Amortization | 111.00K | 50.00K | 20.00K | 160.00K | 310.00K | |||
| Change In Working Capital | 1.69M | 2.68M | -240.00K | -820.00K | 1.07M | |||
| Interest Paid | 2.53M | 1.82M | 1.34M | 980.00K | 1.04M | |||
| Other non cash items | 4.46M | -5.96M | -40.47M | 290.00K | 760.00K | |||
| OPERATING CASH FLOW | -29.55M | -25.90M | -24.89M | 13.84M | -27.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -97.00K | -190.00K | -40.00K | -150.00K | 0.00 | |||
| Other Investing Activity | 14.58M | -17.67M | 610.00K | 0.00 | 90.00K | |||
| INVESTING CASH FLOW | 14.48M | -17.86M | 570.00K | -150.00K | 80.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 5.90M | -2.00M | 0.00 | |||
| Stock Issued/Repurchased | 21.23M | 2.80M | 60.00K | 110.00K | 20.34M | |||
| Other Financing Activity | 0.00 | -40.00K | 52.86M | 0.00 | -90.00K | |||
| FINANCING CASH FLOW | 21.23M | 2.77M | 58.81M | -1.89M | 20.24M | |||
| CHANGE IN CASH | 6.17M | -40.99M | 34.49M | 11.80M | -7.28M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.55M | -25.90M | -24.89M | 13.84M | -27.60M | |||
| Capital Expenditure | -97.00K | -190.00K | -40.00K | -150.00K | 0.00 | |||
| FREE CASH FLOW | -29.65M | -26.09M | -24.93M | 13.69M | -27.60M | |||
All data in USD